Watch ACRV. Know when insiders buy.
One email the day a filing lands. Free.
ACRV
Acrivon Therapeutics, Inc.
1.83
+0.03 +1.67%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
60
WATCH · insiders 48, shorts 71
Insiders, 90 days
−$35K
net selling · 0 buys, 3 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $78.2MP/E —DIV YIELD —FCF YIELD -82.01%REV TTM —NET INCOME −$74.2MNET CASH —52W 1.29 – 3.01SEC XBRL · TTM TO Invalid Date
Insider trading
−$35K
Net, 90 days
0 / 3
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
| Traded | Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 25 | Aug 27 | Blume-Jensen Peter · President and CEO | Sell | 14,036 | $2.21 | $31K |
| Aug 18 | Aug 20 | Devroe Eric · Chief Operating Officer | Sell | 604 | $2.01 | $1K |
| Aug 18 | Aug 20 | Blume-Jensen Peter · President and CEO | Sell | 1,229 | $2.01 | $2K |
Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.